RE:New 52 week low Howie just has to provide guidance on when AbbVie expects to launch, or if they plan to. But like others have said, he has ran out of fingers to stick in the holes of the Dam and public unpalatableness is now overflowing. People want out of this disgrace and willing to settle for whatever residual value they can get from their shrinking equity. The share price is heading to Zero and Howie is pleased to provide updates. He is hoping for investments from future partners that like his samples? That's his game plan? What about revenue from AbbVie to fund the up scale and commercialization of the anti-aging agents? If revenue was expected that was supposed to make us profitable, why does he want to continue to dilute?